Chronic THC intake modifies fundamental cerebellar functions

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3208-3210

  Stella, Nephi ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; DRONABINOL;

BRAIN FUNCTION; DOWN REGULATION; DRUG EFFECT; DRUG SAFETY; EYELID REFLEX; GENETICS; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CEREBELLAR DISEASES; MALE; MICROGLIA; TETRAHYDROCANNABINOL;

EID: 84881225826     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI70226     Document Type: Review

References (18)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346(6284):561-564.
2. Steindel F, et al. Neuron-type specific cannabinoidmediated G protein signalling in mouse hippocampus. J Neurochem. 2013;124(6):795-807.
3. Berghuis P, et al. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science. 2007;316(5828):1212-1216.
4. Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med. 2008;14(9):923-930.
5. Kreitzer AC, Malenka RC. Endocannabinoidmediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature. 2007;445(7128):643- 647.
6. Robbe D, Montgomery SM, Thome A, Rueda- Orozco PE, McNaughton BL, Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci. 2006;9(12):1526-1533.
7. Marsicano G, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science. 2003;302(5642):84-88.
8. Straiker A, Mackie K. Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years. AAPS J. 2006;8(2):E272-E276.
9. Cutando L, et al. Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J Clin Invest. 2013;123(7):2816-2831.
10. Skosnik PD, Edwards CR, O'Donnell BF, Steffen A, Steinmetz JE, Hetrick WP. Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology. 2008; 33(6):1432-1440.
11. Tonini R, et al. ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta9- tetrahydrocannabinol exposure. J Neurosci. 2006;26(21):5810-5818.
12. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia. 2010;58(9):1017-1030.
13. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology. 2009;1:244-253.
14. Molina-Holgado F, et al. Endogenous interleukin- 1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci. 2003; 23(16):6470-6474.
15. Jones RT, Benowitz N, Bachman J. Clinical studies of cannabis tolerance and dependence. Ann N Y Acad Sci. 1976;282:221-239.
16. Braitenberg V, Heck D, Sultan F. The detection and generation of sequences as a key to cerebellar function: experiments and theory. Behav Brain Sci. 1997;20(2):229-245.
17. Mathew RJ, Wilson WH, Turkington TG, Coleman RE. Cerebellar activity and disturbed time sense after THC. Brain Res. 1998;797(2):183-189.
18. O'Leary DS, et al. Marijuana alters the human cerebellar clock. Neuroreport. 2003;14(8):1145-1151.